Molecular mechanisms of osteosarcoma metastasis and possible treatment opportunities

X Du, H Wei, B Zhang, B Wang, Z Li, LK Pang… - Frontiers in …, 2023 - frontiersin.org
In osteosarcoma patients, metastasis of the primary cancer is the leading cause of death. At
present, management options to prevent metastasis are limited and non-curative. In this …

Osteosarcoma and metastasis

G Sheng, Y Gao, Y Yang, H Wu - Frontiers in oncology, 2021 - frontiersin.org
Osteosarcoma is the most common primary bone malignancy in adolescents. Its high
propensity to metastasize is the leading cause for treatment failure and poor prognosis …

Molecular alterations associated with osteosarcoma development

K Ando, K Mori, F Verrecchia, B Marc, F Rédini… - Sarcoma, 2012 - Wiley Online Library
Osteosarcoma is the most frequent malignant primary bone tumor characterized by a high
potency to form lung metastases which is the main cause of death. Unfortunately, the …

[HTML][HTML] Molecular pathogenesis and therapeutic strategies of human osteosarcoma

SK Denduluri, Z Wang, Z Yan, J Wang… - Journal of Biomedical …, 2016 - ncbi.nlm.nih.gov
Osteosarcoma (OS) is a devastating illness with rapid rates of dissemination and a poor
overall prognosis, despite aggressive standard-of-care surgical techniques and combination …

Understanding and modeling metastasis biology to improve therapeutic strategies for combating osteosarcoma progression

TM Fan, RD Roberts, MM Lizardo - Frontiers in oncology, 2020 - frontiersin.org
Osteosarcoma is a malignant primary tumor of bone, arising from transformed progenitor
cells with osteoblastic differentiation and osteoid production. While categorized as a rare …

Molecular pathology of osteosarcoma

F Fei, S Harada, S Wei, GP Siegal - … and Bone Metastases-From Bench to …, 2022 - Elsevier
Osteosarcoma is an extremely genetically unstable tumor with multiple numerical and
structural chromosomal alterations. Chromothripsis and alternative lengthening of telomeres …

Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature

J PosthumaDeBoer, MA Witlox, GJL Kaspers… - Clinical & experimental …, 2011 - Springer
Treating metastatic osteosarcoma (OS) remains a challenge in oncology. Current treatment
strategies target the primary tumour rather than metastases and have a limited efficacy in the …

Toward a drug development path that targets metastatic progression in osteosarcoma

C Khanna, TM Fan, R Gorlick, LJ Helman… - Clinical Cancer …, 2014 - AACR
Despite successful primary tumor treatment, the development of pulmonary metastasis
continues to be the most common cause of mortality in patients with osteosarcoma. A …

Metastatic progression of osteosarcomas: a review of current knowledge of environmental versus oncogenic drivers

GA Odri, J Tchicaya-Bouanga, DJY Yoon, D Modrowski - Cancers, 2022 - mdpi.com
Simple Summary Osteosarcomas are heterogeneous bone tumors with complex genetic and
chromosomic alterations. The numerous patients with metastatic osteosarcoma have a very …

Key genes with prognostic values in suppression of osteosarcoma metastasis using comprehensive analysis

M Li, X Jin, H Li, G Wu, S Wang, C Yang, S Deng - BMC cancer, 2020 - Springer
Background Osteosarcoma is a primary malignant tumor originating from mesenchymal
tissue, with a poor distant metastasis prognosis. The molecular mechanisms of …